Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 6 Leukemia, Myeloid, Acute 3 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Locally Advanced Thyroid Gland Carcinoma 1 Liver Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 HCC 1 Fibrolamellar hepatocellular carcinoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Temozolomide 16 Irinotecan 13 Cyclophosphamide 11 dinutuximab 9 naxitamab 7 Vincristine 7 Carboplatin 6 sargramostim 5 Melphalan 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Etoposide 5 fludarabine 4 Topotecan 4 Thiotepa 4 Eflornithine 4 Doxorubicin 4 Cisplatin 4 etoposide phosphate 3 Zoledronic Acid 3 Specimen Handling 3 Isotretinoin 3 Granulocyte Colony-Stimulating Factor 3 saponin QA-21V1 2 lutetium Lu 177 dotatate 2 aldesleukin 2 Vorinostat 2 Stem Cell Transplantation 2 Radiation 2 Platinum 2 Mesna 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neuroblastoma × Sorafenib × Clear all

NCT02559778 2026-04-28

PEDS-PLAN

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡